ARMP
Armata Pharmaceuticals Inc
3.60$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2.5 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 | 1.5 | 1.0 | 0.0 | 3.0 | 1.2 | 0.5 | 2.2 | 1.2 | 1.1 | 0.8 | 2.5 | 5.5 | |
| 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | 1.8 | |
| 1.0 | 1.2 | 0.6 | -0.3 | 2.7 | 0.9 | 0.1 | 1.8 | 0.8 | 0.7 | 0.3 | 1.9 | 3.7 | |
| 8.0 | 7.9 | 8.0 | 8.5 | 9.5 | 8.5 | 5.4 | 6.4 | 5.8 | 6.1 | 6.1 | 7.6 | 26 | |
| 3.6 | 3.2 | 3.2 | 3.4 | 3.2 | 3.3 | 3.3 | 2.6 | 3.1 | 3.4 | 3.5 | 5.2 | 15 | |
| 11 | 11 | 11 | 12 | 12 | 11 | 8.3 | 8.6 | 7.8 | 14 | 9.1 | 12 | 43 | |
| -10 | -9.6 | -10 | -12 | -9.8 | -11 | -8.2 | -6.8 | -7.8 | -14 | -8.8 | -10 | -41 | |
| 1.2 | 1.5 | 1.8 | 2.7 | 2.9 | 3.3 | 3.6 | 3.8 | 4.3 | 4.8 | 5.6 | 6.6 | 21 | |
| -31 | -20 | -25 | 9.0 | -5.5 | 2.6 | -6.5 | -16 | -27 | -124 | -115 | 74 | -192 | |
| -15 | 18 | 0.3 | – | – | -0.3 | – | – | – | – | – | – | – | |
| -31 | -20 | -25 | 9.0 | -5.5 | 2.6 | -6.5 | -16 | -27 | -124 | -115 | 74 | -192 | |
| -30 | -18 | -23 | 12 | -2.2 | 6.3 | -2.6 | -12 | -22 | -119 | -109 | 81 | -169 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.